Analyst firms · Morgan Stanley · NOV

Morgan Stanley NOV price target and rating history

NOV Inc. (NOV) · Consumer Discretionary

Morgan Stanley rates NOV Inc. (NOV) Overweight with a $24 price target, as of its latest action on Jan 4, 2023. It has published 3 rating actions on NOV since July 2021, including 2 upgrades and 0 downgrades. Across 3 firms with a NOV price target in the last 12 months, the median target is $21.

Current rating
Overweight
Price target
$24
Median target, all firms
$21
Actions on NOV
3

Morgan Stanley price target on NOV

$24$21$1720222023202420252026
Morgan Stanley price target on NOV, each point a stated target, July 2021 to January 2023.

Every Morgan Stanley rating on NOV

How other firms rate NOV

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Capital OneOverweight$26Jun 4, 2026
BarclaysUnderweight$21May 7, 2026
RBC Capital MarketsSector Perform$21Apr 14, 2026

Questions about Morgan Stanley and NOV

What is Morgan Stanley's price target for NOV?
Morgan Stanley's latest stated price target for NOV Inc. (NOV) is $24, from its action on Jan 4, 2023.
What is Morgan Stanley's rating on NOV?
Morgan Stanley rates NOV Overweight, a bullish rating, as of Jan 4, 2023.
When did Morgan Stanley last change its view on NOV?
On Jan 4, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $21 to $24.
How does Morgan Stanley's NOV target compare with other analysts?
Across 3 firms with a NOV price target in the last 12 months, the median target is $21.

More NOV rating histories

All Morgan Stanley ratingsNOV news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.